U.S. markets closed
  • S&P 500

    3,841.94
    +73.47 (+1.95%)
     
  • Dow 30

    31,496.30
    +572.16 (+1.85%)
     
  • Nasdaq

    12,920.15
    +196.68 (+1.55%)
     
  • Russell 2000

    2,192.21
    +45.29 (+2.11%)
     
  • Crude Oil

    66.28
    +2.45 (+3.84%)
     
  • Gold

    1,698.20
    -2.50 (-0.15%)
     
  • Silver

    25.30
    -0.17 (-0.65%)
     
  • EUR/USD

    1.1925
    -0.0054 (-0.45%)
     
  • 10-Yr Bond

    1.5540
    +0.0040 (+0.26%)
     
  • GBP/USD

    1.3827
    -0.0067 (-0.48%)
     
  • USD/JPY

    108.2450
    +0.2690 (+0.25%)
     
  • BTC-USD

    48,779.55
    +1,679.15 (+3.57%)
     
  • CMC Crypto 200

    982.93
    +39.75 (+4.21%)
     
  • FTSE 100

    6,630.52
    -20.36 (-0.31%)
     
  • Nikkei 225

    28,864.32
    -65.78 (-0.23%)
     

Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2020

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

AUSTIN, Texas, Oct. 22, 2020 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the third quarter ended September 30, 2020 on Thursday, November 5, 2020. A press release announcing the results is scheduled for release after the close of trading on that date.

Management will hold a conference call to discuss the operating highlights and financial results for the third quarter ended September 30, 2020 on November 5, 2020, at 5:00 p.m. Eastern Time.

The conference call will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com. Simply log on to the website, go to the About Luminex section and access the Investor Relations link. If you are unable to participate during the live webcast, the call will be archived for six months on the website using the 'replay' link.

About Luminex Corporation

At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at www.luminexcorp.com.

Luminex Corporate Contact:
Harriss Currie
Sr. Vice President, Finance and CFO
512.219.8020
hcurrie@luminexcorp.com

Investor Relations Contact:
Carla Stanaford
937.469.2120
cstanaford@luminexcorp.com

Luminex logo. (PRNewsFoto/Luminex Corporation)
Luminex logo. (PRNewsFoto/Luminex Corporation)
Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/luminex-corporation-third-quarter-earnings-release-scheduled-for-november-5-2020-301157528.html

SOURCE Luminex Corporation